Entering text into the input field will update the search result below

Inovio Pharmaceuticals (INO) Investor Presentation - Slideshow

Oct. 01, 2021 1:09 PM ETInovio Pharmaceuticals, Inc. (INO)2 Comments
SA Transcripts profile picture
SA Transcripts

The following slide deck was published by Inovio Pharmaceuticals, Inc. in conjunction with this event.

Powering a New Decade of DNA Medicines

This article was written by

SA Transcripts profile picture
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Recommended For You

Comments (2)

page 5 "DEMONSTRATED CLINICAL EFFICACY": shouldn't it be the FDA to decide that?? VGX3100 is still in Phase 3.
page 14: "second generation COVID.." : these clowns haven't even delivered on a first generation viable vaccine yet and they are already touting a "second gen"? How scammy is that.
page 3: "STRONG and experienced management team": enuff said!!! Only experience is at scamming shareholders if you ask me... That -they are pretty good at!
Of course the market is pretty at seeing through these claims and stock is going back down towards the mid single digit where it clearly belongs.... Next year may look bleak for them if they don't start delivering more than vaporware..
Inovio shows 12 treatments under trial for promising DNA treatments which can revolutionize medicine, one hit and then funding will flow, for untreatable cancers and viruses like MERS, SARS, Ebola etc. The lack of funding has delayed progress, but in the USA it's all about big money. The FDA is an expensive bureaucracy to court, but eventually will relent, probably after every medical agency in the world leaves them behind.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

About INO

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on INO

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.